CNMD Conmed Corp.
187
$71.41
$0.66
(0.93%)
| Watchers | 187 |
| 52-Wk Low | $61.05 |
| 52-Wk High | $138.47 |
| Market Cap | $2.18B |
| Volume | 57,101.00 |
| 52-Wk High | $138.47 |
| 52-Wk Low | $61.05 |
CONMED Corporation to Present at the BofA Securities Healthcare ConferenceBusiness Wire • 6 days ago
CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial Officer...
Share to Feed
Latest Ratings for CNMD
DateFirmActionFromTo Jan 2022NeedhamMaintainsBuy Oct 2021NeedhamMaintainsBuy Oct 2021NeedhamUpgradesHoldBuy
View More Analyst Ratings for CNMD
View the Latest...
Fifth Third Bancorp grew its position in CONMED Co. (NYSE:CNMD - Free Report) by 6.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned...
Shares of CONMED Co. (NYSE:CNMD - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seven brokerages that are currently covering the stock, MarketBeat Ratings reports...
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2024 after the market close on Wednesday, April 24, 2024. The Companys management will host...
In this article, we discuss 11 best beaten down dividend stocks to invest in. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Best...
CONMED Co. (NYSE:CNMD Get Free Report) has earned an average rating of Moderate Buy from the seven brokerages that are covering the firm, Marketbeat Ratings reports. One...
Legato Capital Management LLC purchased a new position in CONMED Co. (NYSE:CNMD Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund...
Oak Ridge Investments LLC grew its stake in shares of CONMED Co. (NYSE:CNMD Free Report) by 47.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The...
CONMED (NYSE:CNMD Get Free Report) and Endonovo Therapeutics (OTCMKTS:ENDV Get Free Report) are both medical companies, but which is the better stock? We will contrast the two...